Navigation Links
FDA Approves Hi-Flex Mobile Bearing Knee for Active Adults
Date:1/3/2008

Dr. Mitchell Sheinkop first to perform implant in February

CHICAGO, Jan. 2 /PRNewswire/ -- Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago. Last week, the FDA approved the Zimmer Holdings knee, which is heralded as the next generation of knee prostheses for active adults, especially amateur and professional athletes. Dr. Sheinkop was one of eight physician investigators in the United States who participated in the clinical trial proceeding FDA approval.

The main difference between a fixed bearing, or traditional knee replacement, and a mobile bearing knee is that the articulating surface is free to rotate slightly along with the patient's natural movement.

"The design of this knee allows for better range of motion and improved flexibility for daily activities, whether around the home, at work or during sports and exercise," says Dr. Sheinkop, an orthopedic surgeon and Director of Joint Replacement at the NOHC. "The knee is designed for patients who want high-flexion and have demanding lifestyles/habits. If you want to do deep knee bends, this is the knee you should choose."

Just ask athlete and lawyer Charles Zarzecki, who has a work hard, play hard mentality. Zarzecki, age 50, participated in the clinical trial for the Next Gen LPS-Flex mobile bearing knee and now plays in a Chicago-based USA Hockey team that placed 2nd in the 2007 National Pond Hockey Championships.

"In 2004, I was playing competitive basketball and there was little cartilage left in my knee," says Zarzecki. "After four arthroscopic surgeries, my leg still bowed out, and I knew it was time to do something if I wanted to continue my active lifestyle." Besides hockey, Zarzecki's knee allows him to participate in golfing, biking, spinning and snow skiing.

In 2001, Dr. Sheinkop was first exposed to the mobile bearing knee through an invitation from the Ministry of Health for the United Arab Emirates. At that time he recognized the impact a high performance prosthesis could have to his athletic patients back at home.

The Neurologic & Orthopedic Hospital of Chicago is the country's first freestanding acute care hospital dedicated exclusively to neuroscience and orthopedic services. It utilizes breakthrough technology and minimally invasive techniques as well as advanced procedures for neurosurgery, orthopedics, pain management, neuro-oncology, sports medicine, and rehabilitation.

For more information on mobile bearing knee replacement at the NOHC, call: 773-250-1000 or visit http://www.neuro-ortho.org.


'/>"/>
SOURCE The Neurologic & Orthopedic Hospital of Chicago
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... has received a new patent for its innovative Secure Messaging platform, which includes ... control. The new patent extends Cirius’s portfolio of patents around innovative features ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... wellness and sleep disorder management, today announced it has secured $9 million in ... (WiL) and existing investors. The investment will be used by Somnoware to further ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... announced today the introduction of the innovative newly improved Iso-Hip Wrap. The ... patients. The plush design enhances comfort and enables the patient to enjoy the ...
(Date:5/4/2016)... ... May 04, 2016 , ... a2z, Inc. ... Society™ and Canadian Association for Enterostomal Therapy (CAET) will be utilizing powerful and ... tools to attendees and exhibitors for the 2016 WOCN Society & CAET Joint ...
(Date:5/4/2016)... ... 04, 2016 , ... Washington Wellness Center today announced its tenth anniversary of ... What started out as an idea to provide a holistic approach to wellness has ... Developed by Dr. David Swanekamp, Chiropractic Physician , the wellness center offers a ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... DUBLIN , May 4, 2016 ... the "Global Cancer Stem Cell Therapy Market Outlook ... (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has ... therapeutics are expected to be developed in coming years. ... these techniques. Cancer stem cell therapies are also expected ...
(Date:5/3/2016)... , May 3, 2016  As a teenager, ... contracted rheumatic fever, which damaged his heart. He continued ... But by June 2013, Shepherd,s heart was giving out ... death. On June 20, 2013, the Mesa, ... Artificial Heart (TAH-t). Like a heart transplant, the SynCardia ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology: